. Intra-base pair DNA helix parameters in VAL1-B3-DNA (PDB ID 6fas, this study) and ARF1-B3-DNA (PDB ID 4ldx (9)) structures, as determined by Curves+ web server (24). Supplementary Figure S1 . Contents of the asymmetric unit and oligomeric structure of VAL1-B3.
(A) Two DNA-bound VAL1-B3 subunits that form an asymmetric unit are colored yellow and green. Three adjacent asymmetric units are shown. Two 12 bp DNA oligoduplexes present in the asymmetric unit form continuous DNA structures along the a = 40.09 Å edge of the crystal lattice. Blue and red spheres mark Cα atoms of the N-and Cterminal residues resolved in the structure.
(B) Gel-filtration of VAL1-B3. The apparent MW of apo-VAL1-B3 determined by gelfiltration (18.25 ml elution volume, equivalent to 10.2 kDa, blue square) is close to the theoretic mass of VAL1-B3 monomer (13.3 kDa). Gel-filtration was carried out at room temperature on an AKTA FPLC system using a Superdex 200 10/300 GL column (GE Healthcare) pre-equilibrated with 10 mM sodium phosphate (pH 7.0 at 25°C), 250 mM NaCl and 5 mM 2-mercaptoethanol. The sample (10 μM VAL1-B3) was prepared in 100 μl of the same buffer. Elution from the column (flow rate 0.5 ml/min) was monitored by measuring absorbance at 280 nm. A calibration line was generated by measuring the elution volumes of a series of standards of known molecular mass (Gel Filtration Calibration Kit from GE Healthcare, black circles). The molecular weight of VAL1-B3 was calculated by interpolating its elution volume onto the calibration line.
Supplementary Figure S2 . Overall DNA conformation in complexes with plant B3 domains. Left: structure of the VAL1-B3-DNA complex (PDB ID 6fas, chains BEF). The N-arm residues are colored green, C-arm residues are orange, other residues are yellow. The DNA strands containing the 5′-TGCATG-3′ and 5′-CATGCA-3′ sequences are blue/gray, the DNA axis calculated by the Curves+ web server (24) is red. The total DNA bend as determined by Curves+ is 5.1° (4.7° for the CD strands). Right: structure of the ARF-B3-DNA complex (PDB ID 4ldx, chain A residues 119-226, chain D residues 1-10, chain C residues 12-21). The N-arm residues are colored pale green, C-arm residues are light orange, other residues are pink. The DNA strands containing the 5′-GAGACA-3′ and 5′-TGTCTC-3′ sequences are green/gray, the DNA axis is magenta. The total DNA bend of the shown DNA fragment as determined by Curves+ is 3.1° (5.8° for an equivalent DNA fragment bound by the ARF1 B chain). Center: superimposition of protein chains of VAL1-B3-DNA and ARF1-B3-DNA complexes generated with Multiprot (18) (orientation as in Figure 1D ), showing the slight difference in DNA orientation relative to the proteins.
Supplementary Figure S3 . Contacts of VAL1-B3 residues to DNA backbone. In all panels, electrostatic potential surfaces of wt VAL1-B3 (experimental structure) and the respective mutants (models) are shown. Rotamers for R306 and R345 were selected in COOT (34) such that they could make direct contacts to the phosphates. Positions of free DNA, specific complex and non-specific complex in the EMSA gels are marked by blue, red and yellow rectangles, respectively. (A) DNA binding by wt VAL1-B3 and VAL1-B3 mutants Q345R, E328Q and E360Q. DNA concentration (either non-specific 12/12NSP, or cognate 12/12SP) was 1 µM, protein concentrations were 1, 2, 4 and 10 µM (no protein in lanes '0') , EMSA experiments were performed in a pH 8.3 buffer as described in Materials and Methods. Under these experimental conditions only the mutants are capable of specific complex formation.
(B) Mutations of residues that make direct contacts to DNA phosphates impair specific binding. DNA concentration was 1 µM, VAL1-B3 concentrations were 1, 2, 4 and 10 µM, EMSA experiments were performed in a pH 6.0 buffer as described in Materials and Methods.
Supplementary Figure S4 . The effect of the C-terminal (His) 6 tag on specific and non-specific DNA binding. In all panels, positions of free DNA, specific complex and non-specific complex in the EMSA gels are marked by blue, red and yellow rectangles, respectively. DNA concentration (either non-specific 12/12NSP, or cognate 12/12SP) was 1 µM, protein concentrations were 1, 2, 4 and 10 µM (no protein in lanes '0') , EMSA experiments were performed either in a pH 6.0 or a pH 8. 
SUPPLEMENTARY METHODS

Construction of expression vectors and site-directed mutagenesis
The gene encoding the B3 domain of Arabidopsis thaliana protein VAL1
(UniProtKB Q8W4L5 residues 288-397) with E. coli-optimized codons was synthesized by Invitrogen. The gene of VAL1-B3 was amplified using appropriate primers and inserted into the pLATE31 plasmid (Thermo Fisher Scientific). This generated an E. coli expression vector for the VAL1-B3 domain with a C-terminal (His) 6 tag (C-terminal sequence GHHHHHHG). A VAL1-B3
construct with a C-terminal Strep-tag (C-terminal sequence GWSHPQFEKA) was generated by inserting the amplified synthetic gene containing the tagencoding sequence into the pLATE11 (Thermo Fisher Scientific) plasmid. The protein variant containing an N-terminal (His) 6 tag with a TEV protease site (the overall protein sequence MGSSHHHHHHENLYFQ/GTE-[VAL1 residues 289-397], '/' marking the TEV cleavage site) was cloned into a pETDuet-1 (Novagen)
vector. Mutations were introduced using the 'Phusion mutagenesis kit' (Thermo Fisher Scientific). Sequences of wt and mutant genes were confirmed by Sanger sequencing.
Protein expression and purification
All proteins were expressed in E. coli strain ER2566. Cells were grown in LB broth in the presence of ampicillin at 37°C. When A 600 of the cell culture reached 0.5, the incubation temperature was lowered to 16°C, 0.2 mM IPTG were added, cells incubated for ~16 hours at 16°C and harvested by centrifugation. Cells were sonicated in a buffer containing 20 mM Tris-HCl, pH 8.0, 500 mM NaCl mM, 2 mM phenylmethylsulfonyl fluoride and 7 mM 2-mercaptoethanol. Cleared lysates were collected after centrifugation at 40000 g for 1 h.
The standard wt VAL1-B3 protein and all mutants with the C-terminal (His) 6 tag were purified to >90% homogeneity by chromatography through HisTrap HP chelating column (GE Healthcare) and HiTrap Heparin HP columns (GE Healthcare).
The wt VAL1-B3 protein containing the N-terminal (His) 6 tag with a TEV 
Molecular Replacement
The structure of DNA-bound VAL1-B3 was solved by molecular replacement (MR) with PHASER (16). The initial search model for the MR procedure was an ensemble of 7 VAL1-B3 (residues 287-396) models, generated using the 'Ensembler' function in PHENIX (17). One of the VAL1-B3 models was built automatically by I-TASSER (35), the next model was an I-TASSER model modified using the FoldX (26) 'repair' function (as described below in the section 'Structure analysis with FoldX'), and 5 additional VAL1-B3 models were built manually using MODELLER (36) and HHPRED-generated (37) We note that all attempts to place two copies of any of the individual VAL1-B3 models with PHASER were not successful (PHASER TFZ < 7.5, and no solutions with correct orientation of the subunits among the top-scoring solutions).
Analysis of the EMSA competition experiments
Samples contained VAL1-B3 protein (final concentration 2 μM), radiolabeled cognate 12/12SP DNA, and variable amounts (0.6-20 μM) of unlabeled competitor DNA. The amounts of the radiolabeled specific protein-DNA complexes (i. e., the complex with the 12/12SP DNA) at different competitor concentrations were determined by densitometric analysis of phosphorimager images of EMSA gels, performed using the OptiQuant software (Packard Instrument).
During data analysis we assume two binding equilibria: a protein monomer 'P'
binding to either the radiolabeled DNA 'D' forming the complex 'PD', which is detectable in the gel (complex dissociation constant K D (cognate), equation (1) (2)):
The total concentration of protein in the experiment [PT] is given by eq. 3: 
, 
,
.
Analytical solution of eq. (6) requires the substitution (11)
which converts equation (6) In total, we have tested 20 competitors, 18 variants containing 3 substitutions at each of the 6 positions of the canonical Sph/RY sequence 5'-TGCATG-3', the standard cognate DNA 12/12SP, and the standard non-cognate DNA 12/12NSP as a control (oligonucleotide sequences are listed in Table 1 ).
Competition experiments were performed in duplicate or in triplicate with all DNA variants that showed the strongest ability to compete with cognate DNA. proportion <-function(x){ rs <-sum(x); return(x / rs); } pwm <-apply(df, 1, proportion) pwm <-makePWM(pwm) postscript("val1-b3.eps") seqLogo(pwm) dev.off() #
Structure analysis with FoldX
The structure of VAL1-B3-DNA (chains BEF) was first relaxed using 'RepairPDB' function in FoldX (v. 4) (26) by issuing the command foldx --command=RepairPDB --pdb=input.pdb
The 'repaired' coordinates file was then analyzed using the FoldX function 'Pssm'. Command issued in the case of VAL1-B3-DNA structure was :
foldx --command=Pssm \ --pdb=input_repaired.pdb \ --positions=cE3n,cE4n,aE5n,tE6n,gE7n,cE8n,aE9n,cE10n \ --complexWithDNA=true \ --aminoacids=atgc 1/K D values were converted into a PWM webLogo representation as described above.
